Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorYilmaz, Aysegul
dc.contributor.authorTaghizadehghalehjoughi, Ali
dc.contributor.authorGenc, Sidika
dc.contributor.authorYeni, Yesim
dc.contributor.authorGecili, Ibrahim
dc.contributor.authorHacimuftuoglu, Ahmet
dc.date.accessioned2025-10-16T15:12:53Z
dc.date.issued2024
dc.identifier.doi10.23736/S0390-5616.22.05718-6
dc.identifier.otherWOS:001380699200013
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5655
dc.publisherEDIZIONI MINERVA MEDICA
dc.sourceJOURNAL OF NEUROSURGICAL SCIENCES
dc.subjectGlioblastoma
dc.subjectTemozolomide
dc.subjectHydroxyurea
dc.subjectUlipristal
dc.titleUlipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS